• MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

International Parkinson and Movement Disorders Society Congress

Positive Signs From Prasinezumab in Parkinson Disease: Gennero Pagano, MD, MSc, PhD

October 01, 2021

The expert medical director at Roche provided detail on results from the phase 2 PASADENA study presented at the 2021 MDS Virtual Congress. [WATCH TIME: 3 minutes]

Highlighting the Significant Strides Made in Friedreich Ataxia Care

October 01, 2021

David R. Lynch, MD, PhD, professor of neurology, University of Pennsylvania Perelman School of Medicine, discussed why omaveloxolone’s recent success speaks to the progress made within the FA treatment space.

Cala Trio TAPS Device Reduces Severe Tremor in Patients With ET

September 30, 2021

When used for at least 30 days, it was reported that patients with essential tremor reported improvement in tremor power following 54% of sessions.

NeuroVoices: David R. Lynch, MD, PhD, on the First Potentially Approved Friedreich Ataxia Treatment

September 29, 2021

The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed the state of care for Friedrich ataxia and omaveloxolone’s potential to become its first approved therapy.

Takeaways From MDS 2021: Lisanne Dommershuijsen, MSc

September 27, 2021

Following her presentation at MDS 2021, the PhD candidate in epidemiology at Erasmus University Medical Center discussed highlights from this year’s virtual congress. [WATCH TIME: 2 minutes]

Mechanistic Action and FDA Outlook for Omaveloxolone in Friedreich Ataxia: David R. Lynch, MD, PhD

September 27, 2021

The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed whether omaveloxolone’s therapeutic benefit is enough for it to become the first approved therapy for Friedrich ataxia. [WATCH TIME: 2 minutes]

Developing Interventions to Address Mental Health in Parkinson Disease: Lisanne Dommershuijsen, MSc

September 26, 2021

The PhD candidate in the epidemiology department at Erasmus University Medical Center in the Netherlands discussed the need for tailored treatment in light of the COVID-19 pandemic. [WATCH TIME: 4 minutes]

MDS Congress 2021: Highlights, Takeaways, and Future Research

September 26, 2021

Following MDS 2021, we compiled a roundup of some of our discussions with experts in the Parkinson disease and movement disorders space in one convenient location.

COVID-19 Stressors and Mental Health in Parkinson Disease: Lisanne Dommershuijsen, MSc

September 25, 2021

The PhD candidate in the epidemiology department at Erasmus University Medical Center in the Netherlands discussed the need for tailored treatment in light of the COVID-19 pandemic. [WATCH TIME: 4 minutes]

Victor Sung, MD, on the Cost of Genetic Testing for Huntington Disease

September 24, 2021

The director of the UAB Huntington's Disease Clinic offered his insight on a recent assessment of HD genetic testing at HDSA Centers of Excellence, and the associated costs for patients.